Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Chronic Plaque Psoriasis
NCT01872546Phase 2Completed
- Sponsor
- CHU de Poitiers
- Start
- Jan 2013
- Primary completion
- Apr 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in psoriasis, sponsored by CHU de Poitiers. Started Jan 2013; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01872546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01872546.